BIOHITECH GLOBAL INC (BHTG) Fundamental Analysis & Valuation

NASDAQ:BHTG

Current stock price

0.837
-0.01 (-1.54%)
At close:
0.837
0 (0%)
After Hours:

This BHTG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BHTG Profitability Analysis

1.1 Basic Checks

  • In the past year BHTG has reported negative net income.
BHTG Yearly Net Income VS EBIT VS OCF VS FCFBHTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -14.64%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHTG Yearly ROA, ROE, ROICBHTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 200 -200 400

1.3 Margins

Industry RankSector Rank
OM -54.81%
PM (TTM) -60.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BHTG Yearly Profit, Operating, Gross MarginsBHTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BHTG Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BHTG has more shares outstanding
  • BHTG has a worse debt/assets ratio than last year.
BHTG Yearly Shares OutstandingBHTG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 5M 10M 15M 20M
BHTG Yearly Total Debt VS Total AssetsBHTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M

2.2 Solvency

  • BHTG has an Altman-Z score of -1.97. This is a bad value and indicates that BHTG is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of 5.04 is on the high side and indicates that BHTG has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 5.04
Debt/FCF N/A
Altman-Z -1.97
ROIC/WACCN/A
WACCN/A
BHTG Yearly LT Debt VS Equity VS FCFBHTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.42 indicates that BHTG may have some problems paying its short term obligations.
  • BHTG has a Quick Ratio of 0.42. This is a bad value and indicates that BHTG is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.37
BHTG Yearly Current Assets VS Current LiabilitesBHTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BHTG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.59% over the past year.
  • Looking at the last year, BHTG shows a very strong growth in Revenue. The Revenue has grown by 208.64%.
  • Measured over the past years, BHTG shows a very strong growth in Revenue. The Revenue has been growing by 31.24% on average per year.
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)208.64%
Revenue growth 3Y34.44%
Revenue growth 5Y31.24%
Sales Q2Q%511.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.11% on average over the next years. This is quite good.
  • Based on estimates for the next years, BHTG will show a very strong growth in Revenue. The Revenue will grow by 53.86% on average per year.
EPS Next Y46.66%
EPS Next 2Y24.68%
EPS Next 3Y22.58%
EPS Next 5Y11.11%
Revenue Next Year160.6%
Revenue Next 2Y59.88%
Revenue Next 3Y66.05%
Revenue Next 5Y53.86%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BHTG Yearly Revenue VS EstimatesBHTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
BHTG Yearly EPS VS EstimatesBHTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. BHTG Valuation Analysis

4.1 Price/Earnings Ratio

  • BHTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BHTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHTG Price Earnings VS Forward Price EarningsBHTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -11.32
BHTG Per share dataBHTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • BHTG's earnings are expected to grow with 22.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.68%
EPS Next 3Y22.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BHTG Dividend Analysis

5.1 Amount

  • No dividends for BHTG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BHTG Fundamentals: All Metrics, Ratios and Statistics

BIOHITECH GLOBAL INC

NASDAQ:BHTG (12/10/2021, 8:56:33 PM)

After market: 0.837 0 (0%)

0.837

-0.01 (-1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners18.58%
Ins Owner Change0%
Market Cap23.84M
Revenue(TTM)13.52M
Net Income(TTM)-8.21M
Analysts82.22
Price Target3.57 (326.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.76
P/FCF N/A
P/OCF N/A
P/B 4.17
P/tB N/A
EV/EBITDA -11.32
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.47
BVpS0.2
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -54.81%
PM (TTM) -60.71%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 5.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.37
Altman-Z -1.97
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y46.66%
EPS Next 2Y24.68%
EPS Next 3Y22.58%
EPS Next 5Y11.11%
Revenue 1Y (TTM)208.64%
Revenue growth 3Y34.44%
Revenue growth 5Y31.24%
Sales Q2Q%511.26%
Revenue Next Year160.6%
Revenue Next 2Y59.88%
Revenue Next 3Y66.05%
Revenue Next 5Y53.86%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BIOHITECH GLOBAL INC / BHTG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIOHITECH GLOBAL INC?

ChartMill assigns a fundamental rating of 3 / 10 to BHTG.


What is the valuation status for BHTG stock?

ChartMill assigns a valuation rating of 1 / 10 to BIOHITECH GLOBAL INC (BHTG). This can be considered as Overvalued.


What is the profitability of BHTG stock?

BIOHITECH GLOBAL INC (BHTG) has a profitability rating of 1 / 10.


What is the earnings growth outlook for BIOHITECH GLOBAL INC?

The Earnings per Share (EPS) of BIOHITECH GLOBAL INC (BHTG) is expected to grow by 46.66% in the next year.